SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., Subramaniam S., Blattman J.N., Barber D.L., Ahmed R. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 67084.
  • 2
    Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J. D., Suresh M., Altman J.D., Ahmed R. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188: 220513.
  • 3
    Barber D.L., Wherry E.J., Masopust D., Zhu B.G., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 68287.
  • 4
    Hori J., Wang M.C., Miyashita M., Tanemoto K., Takahashi H., Takemori T., Okumura K., Yagita H., Azuma M. (2006) B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 177: 592835.
  • 5
    Nomi T., Sho M., Akahori T., Hamada K., Kubo A., Kanehiro H., Nakamura S., Enomoto K., Yagita H., Azuma M., Nakajima Y. (2007) Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 13: 215157.
  • 6
    Salama A.D., Chitnis T., Imitola J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. (2003) Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 198: 7178.
  • 7
    Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., Boulassel M.R., Delwart E., Sepulveda H., Balderas R.S., Routy J.P., Haddad E.K., Sekaly R.P. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12: 11981202.
  • 8
    Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., Honjo T. (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8: 76572.
  • 9
    Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., Azuma M., Yagita H. (2002) Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169: 553845.
  • 10
    Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., Greenfield E.A., Liang S.C., Sharpe A.H., Lichtman A.H., Freeman G.J. (2003) Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33: 311726.
  • 11
    Kozako T., Yoshimitsu M., Fujiwara H., Masamoto I., Horai S., White Y., Akimoto M., Suzuki S., Matsushita K., Uozumi K., Tei C., Arima N. (2009) PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia 23: 37582.
  • 12
    Shimauchi T., Kabashima K., Nakashima D., Sugita K., Yamada Y., Hino R., Tokura Y. (2007) Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. Int J Cancer 121: 258590.
  • 13
    Chen L.G., Zhang Z., Chen W.W., Zhang Z.D., Li Y.G., Shi M., Zhang J.Y., Chen L.P., Wang S.D., Wang F.S. (2007) B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 178: 663441.
  • 14
    Wang X.C., Zhang Z., Zhang S.Y., Fu J.L., Yao J.X., Jiao Y.M., Wu H., Wang F.S. (2008) B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection. Eur J Immunol 38: 322636.
  • 15
    Muthumani K., Choo A.Y., Shedlock D.J., Laddy D.J., Sundaram S.G., Hirao L., Wu L., Thieu K.P., Chung C.W., Lankaraman K.M., Tebas P., Silvestri G., Weiner D.B. (2008) Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism. J Virol 82: 1153644.
  • 16
    Yao Z.Q., King E., Prayther D., Yin D.L., Moorman J. (2007) T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol 20: 27687.
  • 17
    Streeck H., Brumme Z.L., Anastario M., Cohen K.W., Jolin J.S., Meier A., Brumme C.J., Rosenberg E.S., Alter G., Allen T.M., Walker B.D., Altfeld M. (2008) Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. Plos Med 5: 790804.
  • 18
    Kinter A.L., Godbout E.J., McNally J.P., Sereti I., Roby G.A., O'Shea M.A., Fauci A.S. (2008) The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 181: 673846.
  • 19
    Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., Ferrari C. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80: 1139811403.
  • 20
    Velu V., Titanji K., Zhu B.G., Husain S., Pladevega A., Lai L.L., Vanderford T.H., Chennareddi L., Silvestri G., Freeman G.J., Ahmed R., Amara R. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458: 20610.
  • 21
    Sagata N., Yasunaga T., Tsuzukukawamura J., Ohishi K., Ogawa Y., Ikawa Y. (1985) Complete nucleotide-sequence of the genome of bovine leukemia-virus – its evolutionary relationship to other retroviruses. Proc Natl Acad Sci USA 82: 67781.
  • 22
    Gillet N., Florins A., Boxus M., Burteau C., Nigro A., Vandermeers F., Balon H., Bouzar A.B., Defoiche J., Burny A., Reichert M., Kettmann R., Willems L. (2007) Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humans. Retrovirology 4: 18.
  • 23
    Kabeya H., Ohashi K., Onuma M. (2001) Host immune responses in the course of bovine leukemia virus infection. J Vet Med Sci 63: 703708.
  • 24
    Konnai S., Usui T., Ohashi K., Onuma M. (2003) The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Vet Microbiol 94: 28394.
  • 25
    Usui T., Konnai S., Ohashi K., Onuma M. (2007) Interferon-gamma expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep. Vet Immunol Immunopathol 115: 1723.
  • 26
    Tamura K., Dudley J., Nei M., Kumar S. (2007) MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 159699.
  • 27
    Mingala C.N., Konnai S., Cruz L.C., Onuma M., Ohashi K. (2009) Comparative moleculo-immunological analysis of swamp- and riverine-type water buffaloes responses. Cytokine 46: 27382.
  • 28
    Kaufmann D.E., Walker B.D. (2009) PD-1 and CTLA-4 Inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 182: 589197.
  • 29
    Finnefrock A.C., Tang A.M., Li F.S., Freed D.C., Feng M.Z., Cox K.S., Sykes K.J., Guare J.P., Miller M.D., Olsen D.B., Hazuda D.J., Shiver J.W., Casimiro D.R., Fu T.M. (2009) PD-1 Blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 182: 98087.
  • 30
    Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A. A., Wherry E.J. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 2937.